openPR Logo
Press release

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, H1, 2017: Market Research Hub Reports

Market Research Hub

Market Research Hub

Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Market Research Hub Clinical Trial Reports are generated using Market Research Hubs proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Request For Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1297891

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Browse Full Report with TOC: http://www.marketresearchhub.com/report/chronic-kidney-disease-chronic-renal-failure-global-clinical-trials-review-h1-2017-report.html

Table of Content
Market Research Hub Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Chronic Kidney Disease (Chronic Renal Failure) to Genito Urinary System And Sex Hormones Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Chronic Kidney Disease (Chronic Renal Failure)
Jun 12, 2017: Jardiance (Empagliflozin) Tablets To Be Studied In Chronic Kidney Disease
Jun 09, 2017: Zytoprotec's Novel Dialysis Product Meets Both Endpoints in Phase II Study
Jun 06, 2017: Dimerix hosts US key opinion leader meeting with NephCure Kidney International focused on development path of DMX-200 in kidney disease
May 31, 2017: Resverlogix To Host Epigenetics Focused Symposium At The ERA-EDTA Congress in Madrid, Spain
May 15, 2017: Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Requested Apabetalone Clinical Trial
Clinical Trial Profile Snapshots.
…Continue

Enquire About This Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1297891

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States

Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, H1, 2017: Market Research Hub Reports here

News-ID: 681980 • Views: 237

More Releases from Medical Industry Research Reports - MRH

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Report includes an overview of trial numbers and their average enrollment
Chronic Liver Disease Global Clinical Trials Reviewed H1 – 2017: Pharmaceutica …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Liver Disease Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Liver Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Liver Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review H1 – 2017: Ma …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Tria …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2017 provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia). Report includes an overview of

All 5 Releases


More Releases for Trial

Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Global Clinical Trial Imaging Market
Global Clinical Trial Imaging Market is expected to reach USD 1297.39 Million by 2024 from USD 773.2 Million in 2016 at CAGR of 6.68% (Detailed analysis of the market CAGR is provided in the report). Global Clinical Trial Imaging Market is segmented by product & services, imaging modality, end user, and geography. Imaging Modality segment is classified as magnetic resonance imaging, computed tomography, positron emission tomography, ultrasound and others. Computed Tomography
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. The patent protection assigned to Humira will expire in 2016 for US and 2018 for European market.
Global Dysthymia Clinical Trial Market
The Dysthymia Clinical Trial Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Dysthymia is often characterized by chronic depression. Symptoms of dysthymia are the same as for depression and usually not as severe as major depression. Key symptom of dysthymia is daily
Thompson & Knight Expands Trial Practice
Dallas (August 15, 2011) – The global law firm of Thompson & Knight LLP is pleased to announce that Nathan H. Aduddell* has joined the Firm’s Trial Department as an Associate in the Dallas office. “Nathan comes to us with an excellent record of scholastic achievement and success in trial-related competitions, all accomplishments we believe will enhance his trial skills. We are very pleased to have him join